INTEST CORP Net Income Loss

• INTEST CORP showed a decrease of -187.4% in Net Income Loss from 2024 to 2025.
• This data is from INTEST CORP's annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2017: $1.45 million | Q3 2017: $2.02 million | Q4 2017: -$4.57 million | Q1 2018: $381.0 thousand | Q2 2018: $4.01 million | Q3 2018: -$566.0 thousand | Q4 2018: -$792.0 thousand | Q1 2019: $1.14 million | Q2 2019: -$187.0 thousand | Q3 2019: $647.0 thousand | Q4 2019: $724.0 thousand | Q1 2020: -$1.14 million | Q2 2020: $170.0 thousand | Q3 2020: $458.0 thousand | Q4 2020: -$380.0 thousand | Q1 2021: $2.21 million | Q2 2021: $2.61 million | Q3 2021: $2.18 million | Q4 2021: $287.0 thousand | Q1 2022: $577.0 thousand | Q2 2022: $2.12 million | Q3 2022: $2.52 million | Q4 2022: $3.24 million | Q1 2023: $2.82 million | Q2 2023: $2.79 million | Q3 2023: $2.28 million | Q4 2023: $1.46 million | Q1 2024: $662.0 thousand | Q2 2024: $230.0 thousand | Q3 2024: $495.0 thousand | Q4 2024: $1.50 million | Q1 2025: -$2.33 million | Q2 2025: -$503.0 thousand | Q3 2025: -$938.0 thousand.
• Over the full 13 years of available data (2013 to 2025), INTEST CORP's Net Income Loss has declined by 182.1%.
• Historical annual values: Fiscal year 2025: -$2.53 million | Fiscal year 2024: $2.89 million | Fiscal year 2023: $9.34 million | Fiscal year 2022: $8.46 million | Fiscal year 2021: $7.28 million | Fiscal year 2020: -$895.0 thousand | Fiscal year 2019: $2.32 million | Fiscal year 2018: $3.04 million | Fiscal year 2017: $975.0 thousand | Fiscal year 2016: $2.66 million | Fiscal year 2015: $1.86 million | Fiscal year 2014: $3.44 million | Fiscal year 2013: $3.08 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026